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Introduction: Noncompaction cardiomyopathy (NCCM) is a rare congenital cardiomyopathy characterised 
by a distinctive 2-layered appearance of the myocardium due to hypertrabecularisation and deep intertrabec-
ular recesses. The present study was designed to assess left atrial (LA) volumes and volumetric and strain-
based functional properties by three-dimensional speckle-tracking echocardiography (3DSTE) in NCCM.
Methods: The study included 12 consecutive NCCM patients. Their results were compared to 20 age- and 
sex-matched healthy controls. Complete two-dimensional Doppler echocardiography and 3DSTE were per-
formed in all cases.
Results: Calculated LA maximum (76.5 ± 26.8 mL vs. 45.3 ± 15.1 mL, p=0.0002) and minimum (56.9 
± 27.3 mL vs. 25.3 ± 15.2 mL, p=0.0002) volumes and LA volume before atrial contraction (67.1 ± 28.2 
mL vs. 35.7 ± 16.4 mL, p=0.0004) were significantly greater in NCCM patients. Total, active, and passive 
LA emptying fractions proved to be smaller in NCCM. Peak global radial (-9.3 ± 7.8% vs. -16.8 ± 10.2%, 
p=0.05), circumferential (12.8 ± 8.4% vs. 26.2 ± 9.2%, p=0.0003), longitudinal (12.8 ± 8.2% vs. 22.5 
± 8.5%, p=0.004), and area (26.7 ± 18.5% vs. 51.6 ± 20.3%, p=0.001) strains were significantly small-
er in NCCM patients as compared to matched controls.
Conclusions: Significantly greater LA volumes and compromised LA functional properties could be demon-
strated by 3DSTE in patients with NCCM.
N oncompaction of the left ventric-ular (LV) myocardium is a rare congenital cardiomyopathy char-
acterised by a distinctive 2-layered ap-
pearance of the myocardium due to hy-
pertrabecularisation and deep intertra-
becular recesses.1 It usually presents with 
ventricular dysfunction, thromboembolic 
events and arrhythmias. However, little is 
known about the behaviour of the left atri-
um (LA) in noncompaction cardiomyop-
athy (NCCM) at this time.2 Several non-
invasive clinical tools, including three-di-
mensional (3D) speckle-tracking echo-
cardiography (STE), have been demon-
strated to be useful for the assessment of 
LA function.3 The present study was de-
signed to assess LA volumes and volume- 
and strain-based functional properties by 
3DSTE in NCCM.
Methods
Patient population
The present study included 12 patients 
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with typical features of NCCM. The diagnosis of NC-
CM was confirmed in all patients according to Jen-
ni’s criteria.1 Their results were compared to 20 age- 
and sex-matched healthy controls. Complete two-
dimensional (2D) Doppler echocardiography and 
3DSTE were performed in all NCCM cases and con-
trols. Diabetes mellitus (DM) was defined in accor-
dance with the criteria of the American Diabetes As-
sociation4 and World Health Organisation.5 Hyper-
tension was defined as either a systolic or a diastolic 
elevation of the blood pressure (>140/90 mmHg), or 
ongoing antihypertensive therapy. Hypercholester-
olemia was defined as a total cholesterol level >5.0 
mmol/L or current treatment with lipid-lowering 
medications. All subjects were enrolled in the MAG-
YAR-Path Study (Motion Analysis of the heart and 
Great vessels bY three-dimensionAl speckle-tRack-
ing echocardiography in Pathological cases). This 
was organised at the Cardiology Centre of the Uni-
versity of Szeged to evaluate the usefulness, diagnos-
tic and prognostic value of 3DSTE-derived volumet-
ric, strain, rotational, dyssynchrony, etc., parameters 
in pathological cases (“Magyar” means “Hungarian” 
in the Hungarian language). Informed consent was 
obtained from each patient and control subject and 
the study protocol conformed to the ethical guide-
lines of the 1975 Declaration of Helsinki, as reflect-
ed in a priori approval by the institution’s human re-
search committee.
Two-dimensional echocardiography
Complete Doppler 2D echocardiographic examina-
tions were performed in all cases. Standard 2D echo-
cardiographic studies were carried out using commer-
cially available Toshiba Artida™ echocardiography 
equipment (Toshiba Medical Systems, Tokyo, Japan) 
with a PST-30SBP (1-5 MHz) phased-array trans-
ducer. Left ventricular (LV) and LA dimensions, vol-
umes and LV ejection fraction (EF) were calculated 
in accordance with the guidelines.6 Colour Doppler 
echocardiography was used to visually quantify the 
degree of mitral regurgitation.
Three-dimensional speckle-tracking echocardiography
All patients underwent 3D echocardiographic ac-
quisitions immediately after a 2D echocardiographic 
study, using the same Toshiba Artida™ echocardiog-
raphy equipment and a commercially available PST-
25SX matrix-array transducer with 3DSTE capabil-
ity.3,7 Within a single breath-hold and during a con-
stant RR interval, 6 wedge-shaped subvolumes were 
acquired from an apical window to create full-volume 
3D datasets. The sector width was decreased as much 
as possible to improve the temporal and spatial reso-
lution of the image in order to obtain a 3D full-vol-
ume dataset of the LA with optimal border delinea-
tion. LA chamber quantification was performed off-
line using 3D Wall Motion Tracking software ver-
sion 2.5 (Toshiba Medical Systems, Tokyo, Japan). 
Three-dimensional echocardiographic datasets were 
displayed in apical 4-chamber (AP4CH) and 2-cham-
ber (AP2CH) views and 3 short-axis views in basal, 
mid-atrial, and superior LA regions (Figure 1). In 
the AP4CH and AP2CH views, the endocardial bor-
der was traced by the user, who set multiple reference 
points starting at the base of the LA at mitral valve 
level, progressing toward the LA apex, and excluding 
the LA appendage and pulmonary veins from the LA 
cavity. The epicardial border was adjusted manually 
or by setting a default thickness for the myocardium. 
After detection of the LA borders on the end-diastol-
ic reference frame, 3D wall motion tracking, which is 
based on a 3D block-matching algorithm, was auto-
matically performed by the software. The user could 
correct the shape of the LA if needed throughout the 
entire cardiac cycle.
3DSTE-derived volumetric measurements
The following volumetric calculations were per-
formed:3,7
1. maximum LA volume (Vmax) at end-systole, the 
time at which LA volume was largest just before 
mitral valve opening,
2. minimum LA volume (Vmin) at end-diastole, the 
Table 1. The way of calculating left atrial stroke volumes and emptying fractions in each phase of left atrial motion.
Reservoir Conduit function Active contraction
Stroke volumes (mL) Total SV = Vmax - Vmin Passive SV = Vmax - VpreA Active SV = VpreA - Vmin
Emptying fractions (%) Total EF = Total SV/Vmax Passive EF = Passive SV/Vmax Active EF = Active SV/VpreA
EF – ejection fraction; LV – left ventricular; SV – stroke volume; Vmax – maximum left atrial volume; Vmin – minimum left atrial volume; VpreA – left atrial 
volume before left atrial contraction.
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time at which LA volume reaches its nadir before 
mitral valve closure,
3. LA volume before atrial contraction (VpreA), the 
last frame before mitral valve reopening or at the 
time of the P wave on the ECG.
From these three volumes, several parameters 
characterising all phases of LA function (reservoir, 
conduit and active contraction) including total, active 
and passive LA stroke volumes and emptying frac-
tions, were derived (Table 1).
3DSTE-derived strain measurements
The following peak strain parameters were routinely 
measured by the software in a semi-automatic fashion 
from the 3D echocardiographic datasets to character-
ise LA reservoir function:3,7-9 longitudinal strain (LS) 
in the direction tangential to the endocardial contour, 
circumferential strain (CS) in a circumferential direc-
tion, and radial strain (RS) in a perpendicular direc-
tion to the endocardial contour. Besides these “unidi-
mensional” parameters, novel strain parameters were 
Long. Strain
Long. Strain
[%]
[%]
45.0
30.00
-30.00
30.0
15.0
0.0 [msec]-5.40
51.25 Time: 0 msec
EDV 47.03 mL 433 msec
0 msec
est. MASS
ESV 22.81 mL
EF 54.50%
1.05*MV 18.55 g
Figure 1. Images from three-dimensional full-volume dataset showing left atrium: (A) apical four-chamber view, (B) apical two-chamber 
view, (C3) parasternal short-axis view at basal, (C5) mid- and (C7) superior left atrial level. The semi-automated left atrial border defini-
tion, left atrial volumetric data and three-dimensional “wire” reconstruction of the left atrium based on three-dimensional speckle tracking 
echocardiographic analysis, together with time-segmental longitudinal strain curves are also presented.
C3 Α Β
C5
C7
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also recorded, such as 3D strain (3DS), defined as 
strain in the wall-thickening direction, and area strain 
(AS), as a ratio of endocardial area change during the 
cardiac cycle.
Statistical analysis
All data are reported as mean ± standard deviation. 
A value of p<0.05 was considered to be statistically 
significant. For comparing variables, Student’s t-test, 
chi-square analysis, and Fisher’s exact test were used. 
MedCalc software was used for the statistical calcula-
tions (MedCalc, Mariakerke, Belgium).
Results
Clinical characteristics of patients
Cardiovascular risk factors and medications of NC-
CM patients and controls are presented in Table 2.
Two-dimensional echocardiographic data
Standard 2D echocardiographic data are summarised 
in Table 2. Significant (>grade 2) mitral regurgita-
tion could be detected in 4 patients with NCCMP 
(33%) and in none of the controls. Increased LV di-
ameters and volumes, and decreased LV-EF could be 
confirmed in NCCM patients (Table 2).
Three-dimensional speckle-tracking echocardiographic 
data
Significantly increased LA maximum and minimum 
volumes and LA volume before atrial contraction 
could be detected in NCCM patients. Total, passive 
and active LA emptying fractions were significant-
ly decreased in patients with NCCM (Table 3). Peak 
global and mean LA segmental strains proved to be 
lower in NCCM patients as compared to controls 
(Table 4). Alterations in segmental LA strain param-
eters in NCCM patients are summarised in Table 5. 
The number of noncompacted segments (extent of 
noncompaction) did not correlate with atrial func-
tional properties.
Follow up
The success rate of follow up proved to be 100%. 
During a mean follow up of 27 ± 1 months, cardio-
vascular events were found in the anamnesis of 5 NC-
CM patients, including coronary angiographically-
proven multi-vessel disease requiring coronary artery 
bypass grafting in 2 cases, resynchronisation treat-
Table 2. Clinical and two-dimensional echocardiographic characteristics of patients with noncompaction cardiomyopathy and of controls
 NCCM patients Controls p
 (n=12) (n=20)
Risk factors:
Age (years) 54.2 ± 15.0 51.9 ± 12.7 0.65
Male sex (%) 5 (42) 12 (60) 0.47
Diabetes mellitus (%) 0 (0) 0 (0) 1.00
Hypertension (%) 5 (42) 0 (0) 0.004
Hypercholesterolaemia (%) 3 (25) 0 (0) 0.04
Medications:
β-blockers (%) 10 (83) 0 (0) <0.0001
ACE-inhibitors (%) 10 (83) 0 (0) <0.0001
Diuretics (%) 9 (75) 0 (0) <0.0001
Two-dimensional echocardiography:
LA diameter (mm) 49.4 ± 8.7 33.0 ± 2.0 <0.0001
LV end-diastolic diameter (mm) 62.7 ± 13.2 47.4 ± 4.3 <0.0001
LV end-diastolic volume (mL) 198.8 ± 89.5 104.6 ± 21.1 0.0001
LV end-systolic diameter (mm) 47.7 ± 15.4 31.0 ± 4.3 0.0001
LV end-systolic volume (mL) 116.2 ± 76.5 37.5 ± 10.3 0.0001
Interventricular septum (mm) 10.1 ± 1.8 9.1 ± 2.0 0.17
LV posterior wall (mm) 9.8 ± 1.4 9.8 ± 2.1 1.00
LV ejection fraction (%) 41.5 ± 17.7 64.0 ± 6.1 <0.0001
E/A 1.6 ± 0.7 1.2 ± 0.1 0.02
Number of noncompacted segments 6.5 ± 1.7 0 -
ACE – angiotensin-converting enzyme; LA – left atrium; LV – left ventricular; NCCM – noncompaction cardiomyopathy.
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ment in 1 case, cardiac decompensation and new-on-
set atrial fibrillation in 1 case, and prosthetic valve 
implantation for significant aortic regurgitation and 
pacemaker implantation for ventricular arrhythmias 
in 1 case. 3DSTE-derived atrial volumetric and func-
tional properties in NCCM patients with and without 
events are given in Table 6.
Discussion
3DSTE allows a detailed evaluation of LA function 
through volumetric measurements and strain analy-
sis.3,7 To the best of the authors’ knowledge, this is 
the first study in which LA function was assessed by 
3DSTE in a series of patients with NCCM and com-
pared to matched controls. Increased LA volumes, 
reduced LA emptying fractions and peak LA strain 
parameters could be demonstrated in patients with 
NCCM.
The LA serves multiple functions, acting as a res-
ervoir during LV systole, a conduit for blood transit-
ing from the pulmonary veins to the LV during early 
Table 3. Comparison of three-dimensional speckle-tracking echocardiography-derived left atrial volumetric parameters in patients with 
noncompaction cardiomyopathy and in controls.
 NCCM patients Controls p
 (n=12) (n=20)
Frame rate (vps) 23.2 ± 3.6 19.8 ± 0.8 0.0003
Calculated volumes:
Vmax (mL) 76.5 ± 26.8 45.3 ± 15.1 0.0002
Vmin (mL) 56.9 ± 27.3 25.3 ± 15.2 0.0002
VpreA (mL) 67.1 ± 28.2 35.7 ± 16.4 0.0004
Stroke volumes:
TASV (mL) 19.6 ± 4.8 19.9 ± 6.4 0.89
PASV (mL) 9.5 ± 2.8 9.5 ± 5.3 1.00
AASV (mL) 10.1 ± 5.4 10.3 ± 4.0 0.91
Emptying fractions:
TAEF (%) 29.3 ± 13.1 46.0 ± 13.3 0.002
PAEF (%) 15.1 ± 9.7 22.6 ± 9.0 0.05
AAEF (%) 17.1 ± 8.8 30.7 ± 9.2 0.0003
AAEF – active atrial emptying fraction; AASV – active atrial stroke volume; PSV – passive stroke volume; PAEF – passive atrial emptying fraction; TAEF 
– total atrial emptying fraction; TASV – total atrial stroke volume; Vmax – maximum left atrial volume; Vmin – minimum left atrial volume; VpreA – volume 
before atrial contraction.
Table 4. Comparison of three-dimensional speckle-tracking echo-
cardiography-derived peak global and mean segmental strain pa-
rameters in patients with noncompaction cardiomyopathy and in 
controls.
 NCCM patients Controls p
 (n=12) (n=20)
Peak global:
RS (%) -9.3 ± 7.8 -16.8 ± 10.2 0.05
CS (%) 12.8 ± 8.4 26.2 ± 9.2 0.0003
LS (%) 12.8 ± 8.2 22.5 ± 8.5 0.004
3DS (%) -6.4 ± 5.8 -7.3 ± 12.3 0.81
AS (%) 26.7 ± 18.5 51.6 ± 20.3 0.001
Peak mean segmental:
RS (%) -12.7 ± 6.9 -19.8 ± 8.0 0.02
CS (%) 16.2 ± 9.1 30.9 ± 11.8 0.0009
LS (%) 15.9 ± 8.9 26.1 ± 7.7 0.002
3DS (%) -9.3 ± 5.3 -13.7 ± 9.1 0.32
AS (%) 32.4 ± 20.1 58.9 ± 21.3 0.002
3DS – three-dimensional strain; AS – area strain; CS – circumferential 
strain; LS – longitudinal strain; NCCM – noncompaction cardiomyopathy; 
RS – radial strain.
Table 5. Comparison of three-dimensional speckle-tracking echo-
cardiography-derived peak segmental strain parameters in pa-
tients with noncompaction cardiomyopathy and in controls.
 NCCM patients Controls p 
 (n=12) (n=20)
RSbasal (%) -9.3 ± 6.7 -23.3 ± 11.4 0.0006
RSmid (%) -12.8 ± 6.6 -20.6 ± 11.6 0.04
RSapical (%) -17.9 ± 14.1 -18.8 ± 13.0 0.96
CSbasal%) 16.4 ± 12.3 40.6 ± 14.5 <0.0001
CSmid (%) 14.6 ± 9.2 28.8 ± 12.3 0.002
CSapical (%) 19.1 ± 13.8 25.9 ± 16.7 0.24
LSbasal (%) 13.0 ± 5.7 19.6 ± 10.8 0.06
LSmid %) 21.9 ± 14.2 35.4 ± 10.2 0.004
LSapical (%) 11.6 ± 8.6 20.9 ± 10.9 0.02
3DSbasal (%) -6.5 ± 4.3 -17.7 ± 10.9 0.002
3DSmid (%) -9.2 ± 5.2 -13.3 ± 9.7 0.19
3DSapical%) -13.4 ± 10.2 -12.4 ± 9.0 0.77
ASbasal (%) 27.6 ± 19.0 58.9 ± 26.7 0.001
ASmid (%) 37.4 ± 26.8 69.1 ± 27.8 0.004
ASapical (%) 32.7 ± 23.0 54.5 ± 37.5 0.08
Abbreviations as in Table 4.
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diastole, and an active contractile chamber that aug-
ments LV filling in late diastole.10 Nowadays, there 
are several imaging methodologies that appear to 
make the accurate evaluation of LA volumes and 
functional parameters feasible, including 3DSTE.3,8,9 
3DSTE is based on block matching of the myocardial 
speckles of the endocardial border during their mo-
tion from frame to frame.11 Although volumetric real-
time three-dimensional echocardiography (RT3DE) 
and strain-based 3DSTE are different 3D echocar-
diographic techniques using different algorithms dur-
ing their evaluations, RT3DE and 3DSTE were found 
to give comparable and reproducible quantification 
of LV and LA volumes and function, making inter-
changeable application a viable option in daily clini-
cal practice.12
There are several ways in which 3DSTE could 
characterise LA function:
1. measuring LA volumes with respect to the heart 
cycle and calculating parameters characterising 
all the phases of LA motion detailed above (see 
Table 1);12-14
2. calculating different LA strain parameters from 
the same 3D cast, including RS, LS, CS, 3DS and 
AS;7,15,16
3. measuring LA ejection force from planimetry-
derived mitral annulus data and mitral inflow A- 
wave velocity measured by Doppler echocardiog-
raphy characterising LA systolic function.17
Cardiomyopathies are frequently associated with 
volumetric and functional deterioration of different 
heart chambers.18-20 However, relatively few studies 
are available in which LA (dys)function was investigat-
ed in NCCM. In a recent RT3DE study, LA ejection 
force was found to be greater in NCCM as compared 
to controls.2,17 In the present study, a significantly re-
duced active atrial emptying fraction could be demon-
strated during LA contraction. Moreover, all calculat-
ed LA volumes proved to be increased, while LA emp-
tying fractions with respect to the cardiac cycle were 
decreased in NCCM, demonstrating significant altera-
tions in all aspects of LA function. During strain analy-
sis, certain peak global and mean segmental strain pa-
rameters showed reductions in NCCM patients, con-
firming changes in LA reservoir function.
Limitations
The following important limitations should be taken 
into consideration:
1. The LA appendage and pulmonary veins were 
not considered during LA volumetric and strain 
assessments.
2. 3DSTE-derived image quality is worse than for 
2D echocardiography, because of low temporal 
and spatial image resolution.
3. The results of a relatively small number of NC-
CM patients were analysed. However, it should 
be considered that this was a single-centre experi-
ence and NCCM is a relatively rare disorder.
4. Some NCCM patients showed higher-grade mi-
tral regurgitation. This could have affected our 
results.
Conclusions
Significantly increased LA volumes and reduced LA 
functional properties could be demonstrated in NC-
CM by 3DSTE.
Table 6. Comparison of three-dimensional speckle-tracking echo-
cardiography-derived peak global and mean segmental strain pa-
rameters in noncompaction cardiomyopathy patients with versus 
without events during follow up.
NCCM patients With events Without events p 
 (n=5) (n=7) 
Calculated volumes:
Vmax (mL) 92.0 ± 15.0 65.6 ± 28.6 0.09
Vmin (mL) 73.7 ± 16.2 44.9 ± 28.1 0.07
VpreA (mL) 84.7 ± 16.5 54.5 ± 28.9 0.06
Stroke volumes:
TASV (mL) 18.4 ± 5.7 20.5 ± 4.2 0.47
PASV (mL) 7.3 ± 2.8 11.0 ± 1.5 0.01
AASV (mL) 11.0 ± 6.4 9.5 ± 5.0 0.65
Emptying fractions:
TAEF (%) 20.3 ± 6.3 35.7 ± 13.0 0.04
PAEF (%) 8.3 ± 4.0 20.0 ± 9.7 0.03
AAEF (%) 13.0 ± 6.9 20.1 ± 9.3 0.18
Peak global strains:
RS (%) 5.8 ± 3.9 11.9 ± 9.1 0.19
LS (%) 7.1 ± 3.9 16.9 ± 8.2 0.03
CS (%) 9.3 ± 8.6 15.3 ± 8.0 0.24
3DS (%) 4.6 ± 3.2 7.7 ± 7.0 0.38
AS (%) 15.2 ± 13.8 34.9 ± 17.6 0.06
Mean segmental strains:
RS (%) 9.5 ± 2.8 15.1 ± 8.2 0.18
LS (%) 9.1 ± 3.3 20.8 ± 8.4 0.01
CS (%) 11.3 ± 8.1 19.8 ± 8.6 0.12
3DS (%) 7.3 ± 3.2 10.7 ± 6.2 0.29
AS (%) 19.3 ± 13.6 41.8 ± 19.2 0.05
AAEF – active atrial emptying fraction; AASV – active atrial stroke 
volume; AS – area strain; CS – circumferential strain; LS – longitudinal 
strain; NCCM – noncompaction cardiomyopathy; PAEF – passive atrial 
emptying fraction; PASV – passive stroke volume; RS – radial strain; 
TAEF – total atrial emptying fraction; TASV – total atrial stroke volume; 
Vmax – maximum left atrial volume; Vmin – minimum left atrial volume; 
VpreA – volume before atrial contraction; 3DS – three-dimensional strain.
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